Articles related to Pain Medicine

Manufacturing violations at an Indian facility have triggered a recall of 15 million OTC pain patches, raising concerns about product quality and patient safety across multiple widely-used brands.

Weekly semaglutide administration achieved a 13.7% weight reduction while demonstrating significant improvements in knee osteoarthritis pain, potentially offering a new therapeutic approach for this challenging patient population.

The FDA-designated Class II recall affects specific duloxetine lots where exposure may lead to “temporary or medically reversible health consequences or where the probability of serious adverse health consequences is remote.”

Kratom’s active compounds can produce both stimulant and sedative effects, depending on the dose, but its safety profile and efficacy remain poorly understood.

CGRP inhibitors have shown promise in reducing migraine days and improving quality of life, but their wide-ranging effects throughout the body warrant careful consideration and long-term monitoring.

Recent studies show cannabis use before intercourse helped 67% of women with orgasmic dysfunction achieve improved sexual satisfaction, highlighting its potential as a therapeutic option for female sexual health.